FDA Greenlights Restart of AstraZeneca’s Phase III COVID-19 Vaccine Study
After nearly a month in limbo, AstraZeneca will resume Phase III testing of its COVID-19 vaccine candidate in the United States.
The Home of the Life Sciences Industry
Explore Latest News
FDA COVID-19 Vaccine Advisory Committee: Lots of Talk, No Decisions, Some Reassurance
In the meeting, both the FDA and the U.S. Centers for Disease Control and Prevention presented details about COVID-19 and the requirements for a vaccine.
- BioSpace Movers & Shakers, Oct. 23
- Catalent Boosts Supply Chain Transparency in Response to COVID-19 Manufacturing Urgency
- Research Roundup: Predicting COVID-19 Cytokine Storm and More
- insitro Bolsters Machine-Learning Platform with Haystack Sciences Acquisition
- Study Suggests Bayer’s Finerenone Slows CKD Progression in Patients With Kidney Disease and T2D
Get personalized job alerts
Create a job alert and receive custom job recommendations straight to your inbox.
Employers
Post jobs on BioSpace and start building your talent pipeline today. Click the button to access our easy eCommerce site, which lets you purchase and post jobs in just a few clicks.